206 related articles for article (PubMed ID: 26967005)
41. Male sex as a risk factor for pseudophakic retinal detachment after cataract extraction in Taiwanese adults.
Sheu SJ; Ger LP; Chen JF
Ophthalmology; 2007 Oct; 114(10):1898-903. PubMed ID: 17658608
[TBL] [Abstract][Full Text] [Related]
42. Association between oral fluoroquinolones and retinal detachment.
Albini TA; Karakousis PC; Abbey AM; Bartlett JG; Flynn HW
Am J Ophthalmol; 2012 Dec; 154(6):919-921.e1. PubMed ID: 23149367
[No Abstract] [Full Text] [Related]
43. Occurrence and risk factors for retinal detachment after pars plana vitrectomy in acute postcataract bacterial endophthalmitis.
Chiquet C; Aptel F; Combey-de Lambert A; Bron AM; Campolmi N; Palombi K; Thuret G; Rouberol F; Cornut PL; Creuzot-Garcher C;
Br J Ophthalmol; 2016 Oct; 100(10):1388-92. PubMed ID: 26802175
[TBL] [Abstract][Full Text] [Related]
44. Uveitis risk following oral fluoroquinolone therapy: a nested case-control Study.
Forooghian F; Maberley D; Albiani DA; Kirker AW; Merkur AB; Etminan M
Ocul Immunol Inflamm; 2013 Oct; 21(5):390-3. PubMed ID: 23876164
[TBL] [Abstract][Full Text] [Related]
45. Clinical implications of the association between fluoroquinolones and tendon rupture: The magnitude of the effect with and without corticosteroids.
Persson R; Jick S
Br J Clin Pharmacol; 2019 May; 85(5):949-959. PubMed ID: 30682225
[TBL] [Abstract][Full Text] [Related]
46. Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections.
Meyer CH; Michels S; Rodrigues EB; Hager A; Mennel S; Schmidt JC; Helb HM; Farah ME
Acta Ophthalmol; 2011 Feb; 89(1):70-5. PubMed ID: 21176118
[TBL] [Abstract][Full Text] [Related]
47. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study.
Sodhi M; Sheldon CA; Carleton B; Etminan M
Neurology; 2017 Aug; 89(8):792-795. PubMed ID: 28754842
[TBL] [Abstract][Full Text] [Related]
48. [Epidemiology survey of rhegmatogenous retinal detachment in Beijing districts, Shanghai].
Zou H; Zhang X; Xu X; He Z
Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):580-3. PubMed ID: 12487904
[TBL] [Abstract][Full Text] [Related]
49. Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease.
Muanda FT; Sood MM; Weir MA; Sontrop JM; Ahmadi F; Yoo E; Kim RB; Silverman MS; Knoll GA; Garg AX
JAMA Netw Open; 2022 Aug; 5(8):e2224892. PubMed ID: 35917124
[TBL] [Abstract][Full Text] [Related]
50. Risk of acute kidney injury associated with the use of fluoroquinolones.
Bird ST; Etminan M; Brophy JM; Hartzema AG; Delaney JA
CMAJ; 2013 Jul; 185(10):E475-82. PubMed ID: 23734036
[TBL] [Abstract][Full Text] [Related]
51. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.
Gaba PD; Haley C; Griffin MR; Mitchel E; Warkentin J; Holt E; Baggett P; Sterling TR
Arch Intern Med; 2007 Nov; 167(21):2317-22. PubMed ID: 18039990
[TBL] [Abstract][Full Text] [Related]
52. Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment.
Brown JP; Wing K; Evans SJ; Leyrat C; Mansfield KE; Smeeth L; Wong AYS; Yorston D; Galwey NW; Douglas IJ
JAMA Ophthalmol; 2024 May; ():. PubMed ID: 38814618
[TBL] [Abstract][Full Text] [Related]
53. Incidence rates of retinal detachment in 2 cohorts of patients treated with oral fluoroquinolones or amoxicillin.
Farioli A; Kriebel D
Clin Infect Dis; 2014 May; 58(10):1489-90. PubMed ID: 24610425
[No Abstract] [Full Text] [Related]
54. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
Assimon MM; Pun PH; Wang LC; Al-Khatib SM; Brookhart MA; Weber DJ; Winkelmayer WC; Flythe JE
JAMA Cardiol; 2022 Jan; 7(1):75-83. PubMed ID: 34668928
[TBL] [Abstract][Full Text] [Related]
55. Incidence, mechanism and outcomes of schisis retinal detachments revealed through a prospective population-based study.
Xue K; Muqit MMK; Ezra E; Charles SJ; Yorston D; Mitra A; Patel CK
Br J Ophthalmol; 2017 Aug; 101(8):1022-1026. PubMed ID: 28057646
[TBL] [Abstract][Full Text] [Related]
56. Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study.
Alshammari TM; Larrat EP; Morrill HJ; Caffrey AR; Quilliam BJ; LaPlante KL
Am J Health Syst Pharm; 2014 Jan; 71(1):37-43. PubMed ID: 24352180
[TBL] [Abstract][Full Text] [Related]
57. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
[TBL] [Abstract][Full Text] [Related]
58. Oral fluoroquinolone use and retinal detachment: reconciling conflicting findings in observational research.
Brett AS
JAMA; 2013 Nov; 310(20):2151-3. PubMed ID: 24281459
[No Abstract] [Full Text] [Related]
59. Characteristics of rhegmatogenous retinal detachment after refractive surgery: comparison with myopic eyes with retinal detachment.
Kang HM; Lee CS; Park HJ; Lee KH; Byeon SH; Koh HJ; Lee SC
Am J Ophthalmol; 2014 Mar; 157(3):666-72.e1-2. PubMed ID: 24321470
[TBL] [Abstract][Full Text] [Related]
60. Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study.
Morales DR; Slattery J; Pacurariu A; Pinheiro L; McGettigan P; Kurz X
Clin Drug Investig; 2019 Feb; 39(2):205-213. PubMed ID: 30465300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
